|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Tolerance: Is It Worth the Risk?显示文摘 | James D. Eason Ari J. Cohen Satheesh Nair Teresita Alcantera George E. Loss | 2005 | Transplantation2005，，9： | 2 |
| 2 | Hysteroscopy May Be the Method of Choice for Management of Residual Trophoblastic Tissue显示文摘 | Shlomo B. Cohen Anath Kalter-Ferber Boaz S. Weisz Yaron Zalel Daniel S. Seidman Shlomo Mashiach Arie L. Lidor Mati Zolti Mordechai Goldenberg | 2001 | American Association of Gynecologic Laparoscopists2001，，2： | 2 |
| 3 | Using on-site liver 3-D reconstruction and volumetric calculations in split liver transplantation显示文摘BACKGROUND: Split liver transplantation increases the number of grafts available for transplantation. Pre-recovery assessment of liver graft volume is essential for selecting suitable recipients. The purpose of this study was to determine the ability and feasibility of constructing a 3-D model to aid in surgical planning and to predict graft weight prior to an in situ division of the donor liver. METHODS: Over 11 months, 3-D volumetric reconstruction of 4 deceased donors was performed using Pathfinder Scout~? liver volumetric software. Demographic, laboratory, operative, perioperative and survival data for these patients along with donor demographic data were collected prospectively and analyzed retrospectively.RESULTS: The average predicted weight of the grafts from the adult donors obtained from an in situ split procedure were 1130 g(930-1458 g) for the extended right lobe donors and 312 g(222-396 g) for left lateral segment grafts. Actual adult graft weight was 92% of the predicted weight for both the extended right grafts and the left lateral segment grafts. The predicted and actual graft weights for the pediatric donors were 176 g and 210 g for the left lateral segment grafts and 308 g and 280 g for the extended right lobe grafts, respectively. All grafts were transplanted except for the right lobe from the pediatric donors due to the small graft weight.CONCLUSIONS: On-site volumetric assessment of donors provides useful information for the planning of an in situ split and for selection of recipients. This information may expand the donor pool to recipients previously felt to be unsuitable due to donor and/or recipient weight. | Trevor W Reichman Brittany Fiorello Ian Carmody Humberto Bohorquez Ari Cohen John Seal David Bruce George E Loss | 2016 | Hepatobiliary & Pancreatic Diseases International2016，15，6： | 2 |
| 4 | Capsule Endoscopy Is Superior to Small-bowel Follow-through and Equivalent to Ileocolonoscopy in Suspected Crohn’s Disease显示文摘 | Jonathan A. Leighton Ian M. Gralnek Stanley A. Cohen Ervin Toth David R. Cave Douglas C. Wolf Gerard E. Mullin Scott R. Ketover Peter E. Legnani Ernest G. Seidman Michael D. Crowell Ari J. Bergwerk Ravit Peled Rami Eliakim | 2014 | Clinical Gastroenterology and Hepatology2014，，4： | 1 |
| 5 | Circulating endothe- lial progenitor cells, Th1/Th2/Thl7-related cytokines, and endotheli- al dysfunction in resistant hypertension 显示文摘 | Eli Magen Arie Feldman Ziona Cohen | 2010 | Am J of Med Sci2010，339，2： | 1 |
| 6 | Sclerosing encapsulating peritonitis 显示文摘 | Cohen O Abrahamson J Ben Ari J | 1996 | J Clin Gastroenterol1996，22，1： | 1 |
| 7 | Tourists perceptions of World Heritage Site and its designation显示文摘 | Yaniv Poria Arie Reichel Raviv Cohen | 2013 | Tourism Management2013，，： | 1 |
| 8 | Accuracy of the Preoperative Diagnosis in 100 Emergency Laparoscopies Performed Due to Acute Abdomen in Nonpregnant Women显示文摘 | Shlomo B. Cohen Boaz Weisz Daniel S. Seidman Shlomo Mashiach Arie L. Lidor Mordechai Goldenberg | 2001 | American Association of Gynecologic Laparoscopists2001，，1： | 1 |
| 9 | Sclerosing encapsulating peritonitis显示文摘 | Cohen O Abrahamson J Ben Ari J | 1996 | J Clin Gastroenterol1996，22，1： | 1 |
| 10 | Sclerosing encapsulating peritonitis显示文摘 | Cohen O Abrahamson J Ben Ari J | 1996 | J Clin Gastroenterol1996，22，1： | 1 |
| 11 | Thrombolytic protocol minimizes ischemic‐type biliary complications in liver transplantation from donation after circulatory death donors显示文摘 | John B. Seal Humberto Bohorquez Trevor Reichman Adam Kressel Anand Ghanekar Ari Cohen Ian D. McGilvray Mark S. Cattral David Bruce Paul Greig Ian Carmody David Grant Markus Selzner George Loss | 2015 | Liver Transpl2015，，3： | 1 |
| 12 | Pediatric Capsule Endoscopy: Review of the Small Bowel and Patency Capsules显示文摘 | Stanley A. Cohen Hagit Ephrath Jeffery D. Lewis Alan Klevens Ari Bergwerk Steven Liu Dinesh Patel Bonney Reed-Knight Angela Stallworth Tamara Wakhisi Benjamin D. Gold | 2012 | Journal of Pediatric Gastroenterology and Nutrition2012，，3： | 1 |
| 13 | Surgical Debulking and Intraperitoneal Chemotherapy for Established Peritoneal Metastases From Colon and Appendix Cancer显示文摘 | Alfred T Culliford MD Ari D. Brooks MD Sunil Sharma MD Leonard B. Saltz MD Gary K. Schwartz MD Eileen M. O’Reilly MD David H. Ilson MD Nancy E. Kemeny MD David P. Kelsen MD Jose G. Guillem MD W Douglas Wong MD Alfred M. Cohen MD Philip B. Paty MD | 2001 | Annals of Surgical Oncology2001，，10： | 1 |
| 14 | Links between donor macrosteatosis,interleukin-33 and complement after liver transplantation显示文摘BACKGROUND As prevalence of nonalcoholic fatty liver disease increases in the population,livers with steatosis will continue to infiltrate the donor pool.Safe utilization of these extended criteria grafts is paramount given the increased risk associated with their use in transplantation.Prognostic factors that can predict liver dysfunction immediately after transplantation with macrosteatotic grafts are lacking.AIM To understand the relationship between interleukin-33(IL-33)and complement in recipients immediately following liver reperfusion as a marker of liver dysfunction.METHODS Cohort consisted of patients who received a liver transplant from September 2016–September 2019 at our institution.Clinical variables were retrospectively extracted from the electronic medical record.Back-table donor biopsies were obtained with donor steatosis percentage retrospectively determined by a boardcertified pathologist.Blood samples were available immediately following liver transplantation.Quantification of plasma IL-33 and complement proteins,C3a and C5a,were determined by enzyme-linked immunosorbent assay.For mRNA expression,RNA was extracted from donor biopsies and used against a 780 gene panel.RESULTS Cohort consisted of 99 donor and recipients.Donor median age was 45 years and 55%male.Recipients had a median age of 59 years with 62%male.The main etiologies were alcoholic hepatitis,nonalcoholic steatohepatitis,and hepatocellular carcinoma.Median MELD-Na at transplant was 21.Donors were grouped based on moderate macrosteatosis(≥30%).Recipients implanted with moderate macrosteatotic grafts had significantly higher peak alanine aminotransferase/aspartate aminotransferase(P<0.001 and P<0.004),and increased incidence of early allograft dysfunction(60%compared to 18%).Circulating IL-33 levels were significantly elevated in recipients of≥30%macrosteatotic grafts(P<0.05).Recipients with detectable levels of circulating IL-33 immediately following reperfusion had significantly higher alanine aminotransferase/aspartate aminotransferase(P<0.05 and P<0.01).Activated complement(C3a and C5a)were elevated in recipients implanted with moderate macrosteatotic grafts.RNA expression analysis of donor biopsies revealed moderate steatotic grafts upregulated genes inflammatory processes while downregulated hepatocyte-produced complement factors.CONCLUSION Circulating IL-33 and activated complement levels immediately following liver reperfusion in recipients of moderate macrosteatotic grafts may identify which patients are at risk of early allograft dysfunction. | Kelley Núñez Mohammad Hamed Daniel Fort David Bruce Paul Thevenot Ari Cohen | 2020 | World Journal of Transplantation2020，10，5： | 0 |
| 15 | “Weighing the risk”: Obesity and outcomes following liver transplantation显示文摘Obesity is on the rise worldwide. As a result, unprecedented rates of patients are presenting with end stage liver disease in the setting of non-alcoholic fatty liver disease(NAFLD) and are requiring liver transplantation. There are significant concerns that the risk factors associated with obesity and the metabolic syndrome might have a detrimental effect on the long term outcomes following liver transplantation. In general, short term patient and graft outcomes for both obese and morbidly obese patients are comparable with that of non-obese patients, however, several studies report an increase in peri-operative morbidity and increased length of stay. Continued studies documenting the long-term outcomes from liver transplantation are needed to further examine the risk of recurrent disease(NAFLD) and also further define the role risk factors such cardiovascular disease might play long term. Effective weight reduction in the post liver transplant setting may mitigate the risks associated with the metabolic syndrome long-term. | Trevor W Reichman George Therapondos Maria-Stella Serrano John Seal Rachel Evers-Meltzer Humberto Bohorquez Ari Cohen Ian Carmody Emily Ahmed David Bruce George E Loss | 2015 | World Journal of Hepatology2015，7，11： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员